Dried Blood Spot Collection Cards Market Size, Share, Growth, And Industry Analysis, By Type (Whatman 903, Ahlstrom 226, FTA, & Others), By Application (Hospital, Clinic, and Ambulatory Surgical Centers) Regional Forecast to 2032

Updated On: 29 April 2024

Dried Blood Spot Collection Cards Market Report Overview 

global dried blood spot collection cards market size was USD 284.5 million in 2022 and market is projected to touch USD 343.9 million by 2028 at CAGR 3.2% during the forecast period. 

Dried blood spot (DBS) collection cards are a convenient method for collecting and storing blood samples for various types of analysis, including medical diagnostics, disease screening, and research purposes. A DBS collection card typically consists of a piece of filter paper or other absorbent material. Blood samples are obtained by pricking a finger or heel with a lancet and then applying drops of blood onto the designated area of the collection card. The blood is allowed to dry, and the card is then sealed in a protective pouch or container for storage and transportation.

Healthcare providers, diagnostic laboratories, and research institutions are increasingly adopting DBS cards due to their convenience, cost-effectiveness, and versatility in collecting blood samples. The ease of use and minimal invasiveness make DBS cards particularly attractive for screening, monitoring, and research purposes. Overall, the combination of technological advancements, expanding healthcare infrastructure, increasing demand for decentralized testing solutions, and growing awareness of the benefits of DBS cards is fueling the growth of the market for dried blood spot collection cards.

COVID-19 Impact: Market Faced a Rise in Demand Due to Rise in Demand for Remote Testing Solutions During the Pandemic

The global COVID-19 pandemic has been unprecedented and staggering, with the Dried Blood Spot Collection Cards market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.

With restrictions on movement and social distancing measures in place during the pandemic, there has been an increased demand for remote testing solutions. DBS cards offer a convenient way to collect blood samples remotely, making them particularly valuable for individuals who are unable or unwilling to visit healthcare facilities for traditional blood draws.

Latest Trends

Integration of Advanced Analytical Technologies to Make Market More Efficient

The Dried Blood Spot Collection Cards market is as dynamic as any other market. There's a growing trend toward integrating DBS sampling with advanced analytical technologies such as mass spectrometry, liquid chromatography, and molecular diagnostics. These technologies enhance the sensitivity, specificity, and multiplexing capabilities of assays performed on DBS samples, enabling more comprehensive and accurate analysis of biomarkers and analytes.

Dried Blood Spot Collection Cards Market Segmentation

• By Type Analysis

According to type, the market can be segmented into whatman 903, ahlstrom 226, FTA, & other.

Whatman 903: Whatman 903 is a type of filter paper manufactured by Cytiva (formerly known as GE Healthcare Life Sciences). It is specifically designed for the collection and storage of dried blood spots (DBS) and other biological samples. Whatman 903 filter paper is widely used in newborn screening programs, clinical research, and diagnostic testing due to its high-quality cellulose composition, consistent porosity, and ability to retain biological analytes for extended periods.

Ahlstrom 226: Ahlstrom 226 is another brand of filter paper commonly used for the collection and preservation of biological samples, including blood, saliva, and urine. Like Whatman 903, Ahlstrom 226 filter paper is designed to absorb and retain biological fluids, allowing for the subsequent analysis of biomarkers, DNA, RNA, or other analytes of interest. Ahlstrom 226 filter paper is known for its high purity and uniformity, making it suitable for a wide range of applications in molecular biology and diagnostics.

FTA (Flinders Technology Associates) Cards: FTA cards are a type of specialized filter paper used for the collection and preservation of nucleic acids, such as DNA and RNA, from various biological samples, including blood, buccal swabs, and tissue samples. FTA cards contain chemicals that lyse cells upon contact, denature proteins, and stabilize nucleic acids, allowing for long-term storage at room temperature. FTA cards are often used in forensic DNA analysis, population genetics studies, and epidemiological research due to their convenience and compatibility with downstream molecular techniques.

• By Application Analysis

Based on application, the market can be divided into  hospital, clinic, ambulatory surgical centers.

Hospital: Hospitals often use DBS collection cards for diagnostic testing purposes. These cards allow for the collection, storage, and transportation of blood samples without the need for traditional venipuncture, making them particularly useful in situations where frequent blood sampling is required, such as monitoring patients undergoing treatment or those with chronic conditions.

Clinics: Clinics often use DBS collection cards for point-of-care testing, especially in settings where access to traditional laboratory facilities is limited. These cards enable healthcare providers to collect blood samples on-site and perform various diagnostic tests without the need for immediate processing or refrigeration.

Ambulatory surgical centers: Ambulatory surgical centers may use DBS collection cards for preoperative testing, allowing for the collection of blood samples during preoperative assessments without the need for venipuncture. This approach can streamline the preoperative process and reduce patient anxiety associated with traditional blood collection methods.

Driving Factors

Growing Demand for Point-of-Care Testing has Increased Demand in the Market

With the increasing demand for point-of-care testing (POCT) and decentralized diagnostics, DBS collection cards offer a convenient method for sample collection, transportation, and analysis. The market is thus driven by the need for efficient and accessible diagnostic solutions. Point-of-care testing allows for medical diagnostic testing to be performed closer to the patient, often at the bedside or in a clinic, rather than sending samples to a central laboratory. DBS collection cards offer a convenient and accessible method for collecting blood samples in these settings, as they require minimal equipment and expertise for collection. Overall, the growing demand for point-of-care testing is a driving force behind the increased adoption of dried blood spot collection cards, as they offer a practical and efficient solution for collecting blood samples in diverse healthcare settings.

Rising Prevalence of Infectious Diseases have Influenced the Demand in the Market

Infectious diseases such as HIV, hepatitis, malaria, and others require regular monitoring and screening, especially in resource-limited settings. DBS collection cards provide a simple and cost-effective means of collecting blood samples for diagnostic testing, thereby driving their adoption. Infectious diseases often disproportionately affect populations in remote or resource-limited areas where access to healthcare facilities and laboratory infrastructure is limited. DBS collection cards offer a practical solution for collecting blood samples in these settings, enabling healthcare providers to reach underserved populations and conduct necessary testing without the need for venous blood draws or sophisticated laboratory equipment. In summary, the rising prevalence of infectious diseases drives the demand for DBS collection cards by increasing the need for accessible, convenient, and efficient methods of blood sample collection, especially in resource-limited settings and during outbreaks or pandemics. In this way this factor resulted in Dried Blood Spot Collection Cards market growth. 

Restraining Factor

Regulatory Challenges lead to a Declining Trend in the Market 

Compliance with regulatory requirements can be complex and time-consuming for manufacturers of DBS collection cards. Strict regulations regarding sample collection, transportation, storage, and analysis must be adhered to ensure the accuracy and reliability of test results. Meeting these regulatory standards adds to the cost and time-to-market for DBS collection card products.

Dried Blood Spot Collection Cards Market Regional Insights

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

 North America Region Dominates the Market owing to Large Consumer Base

North America has the largest Dried Blood Spot Collection Cards market share as it boasts advanced healthcare infrastructure with well-established laboratory networks and healthcare systems. This infrastructure facilitates the adoption and integration of innovative diagnostic technologies like DBS collection cards into clinical practice. The region has stringent regulatory standards and guidelines for medical devices and diagnostics, ensuring product safety, efficacy, and quality. Companies operating in North America must adhere to these regulations, fostering trust in DBS collection cards among healthcare professionals and end-users. North America is a hub for research and development (R&D) in the healthcare sector, with significant investments in innovative diagnostic technologies. This environment promotes the development of new and improved DBS collection cards with enhanced features, performance, and usability, driving market growth. The region has a high prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer. DBS collection cards are valuable tools for monitoring biomarkers, drug levels, and disease progression in patients with chronic conditions, contributing to their widespread adoption in North America. North America is home to numerous pharmaceutical and biotechnology companies that develop and manufacture drugs, vaccines, and diagnostic assays. These industries drive demand for DBS collection cards for various applications, including pharmacokinetic studies, clinical trials, and therapeutic drug monitoring.

 Key Industry Players

Key Players Focus on Research & Development and Collaborations for Market Expansion

 Key players invest in research and development efforts to innovate and improve DBS collection card technology. This may involve developing new materials or formulations to enhance sample stability, improving the design of collection cards for easier use and transportation, or expanding the range of tests that can be performed using DBS samples. Key players may engage in collaborations and partnerships with other companies, research institutions, or healthcare organizations to leverage complementary expertise and resources. This may involve joint R&D initiatives, strategic alliances for product distribution or co-marketing agreements, or collaborations to conduct clinical studies and validate the performance of DBS collection card products. Key players manage distribution channels and supply chain logistics to ensure timely delivery of DBS collection cards to customers. This involves working with distributors, wholesalers, and logistics partners to optimize inventory management and meet customer demand.

List of Market Players Profile

• Qiagen(Germany)
• PerkinElmer(U.S.)
• Roche(Switzerland)
• Shimazdu (Novilytic Labs)(Japan)
• Ahlstrom-Munksjö(Finland)

INDUSTRIAL DEVELOPMENT

August 2022: Boston Heart Diagnostics Corporation has introduced an extensive array of tests utilizing dried blood spot collection, catering to diverse applications such as assessing cardiovascular risk factors, type 2 diabetes, and wellness evaluations encompassing cognitive, nutritional, women's, and men's health. 

Report Coverage

The report brings together extensive research on the qualitative and quantitative factors affecting the market. It gives an overall macro and micro view of the online reputation service industry. This research profiles a report with extensive studies on the online reputation management services market that describe the firms affecting the forecasting period. Detailed studies also offer a comprehensive analysis by inspecting factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, and others.

Furthermore, the post-COVID-19 pandemic’s effect on international market restrictions and a deep understanding of how the industry will recover and strategies are also stated in the report. Finally, the competitive landscape has also been examined in detail to provide clarification of the competitive landscape.